Table 4.

The comparison of assessed parameters (qualitative variables) with NRS scores.

Variables		NRS				p-Value *
		<3 (n = 1010)		≥3 (n = 45)
		n	%	n	%
Sex	M	677	67.03	26	57.78	0.20
BMI	<18.5	10	1.35	2	6.06	0.009
	18.5–24.9	189	25.47	14	42.42
	25.0–29.9	253	34.10	11	33.33
	≥30	290	39.08	6	18.18
HF phenotype	HFpEF	290	28.71	14	31.11	0.017
	HFmrEF	126	12.48	4	8.89
	HFrEF	532	52.67	19	42.22
	No information	62	6.14	8	17.78
NYHA	1	89	9.35	3	8.82	0.004
	2	328	34.45	4	11.76
	3	299	31.41	10	29.41
	4	236	24.79	17	50.00
CKD	Yes	375	37.13	20	44.44	0.32
MI	Yes	309	30.59	16	35.56	0.48
Type of MI	No	701	69.4	29	64.4	0.46
	STEMI	83	8.2	6	13.3
	NSTEMI	203	20.1	10	22.2
	No information	23	2.3	29	64.4
HT	Yes	730	72.28	30	66.67	0.41
DM	Yes	445	44.06	10	22.22	0.004
CS	Yes	118	11.68	6	13.33	0.74
LDL	<55 mg/dL	140	14.52	10	27.03	0.16
	55 to <70 mg/dL	161	16.70	4	10.81
	70 to <100 mg/dL	348	36.10	16	43.24
	100 to <116 mg/dL	114	11.83	4	10.81
	116 to <190 mg/dL	189	19.61	3	8.11
	more than 190 mg/dL	12	1.24
LDL	≥70	663	68.78	23	62.16	0.39
TG	<135	672	69.35	29	72.50	0.63
	135–200	201	20.74	6	15.00
	>200	96	9.91	5	12.50
HDL	<40	495	51.08	27	75.00	0.005
	>40	474	48.92	9	25.00

Abbreviations: n, number of participants; M, males; p, level of significance; BMI, body mass index; NRS, nutritional risk screening; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFmrEF, heart failure with mid-range ejection fraction; HFrEF, heart failure with reduced ejection fraction; NYHA, New York Heart Association classification; CKD, chronic kidney disease; MI, myocardial infarction; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; HT, arterial hypertension; DM, diabetes mellitus; CS, cerebral stroke; LDL, low-density lipoprotein; TG, triglycerides; HDL, high-density lipoprotein; * χ² test.